Steven Cohen Ptc Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

$36 Billion
Q2 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 26,700 shares of PTCT stock, worth $947,315. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,700

Previous 26,700 -0.0%

Holding current value

$947,315

Previous $816,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$24.69 - $40.12 $659,223 - $1.07 Million	26,700 New	26,700 $816,000
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $1.41 Million - $2.29 Million	78,100 New	78,100 $2.15 Million
Q1 2022 May 16, 2022	SELL	$33.33 - $44.6 $11.8 Million - $15.8 Million	-355,100 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $5.81 Million - $6.88 Million	-164,300 Reduced 31.63%	355,100 $14.1 Million
Q3 2021 Nov 15, 2021	SELL	$37.01 - $44.74 $5.36 Million - $6.47 Million	-144,715 Reduced 21.79%	519,400 $19.3 Million
Q2 2021 Aug 16, 2021	BUY	$37.95 - $49.37 $22.8 Million - $29.7 Million	600,606 Added 945.7%	664,115 $28.1 Million
Q1 2021 May 17, 2021	SELL	$46.8 - $68.92 $41.3 Million - $60.9 Million	-883,491 Reduced 93.29%	63,509 $3.01 Million
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $7.14 Million - $10.1 Million	-148,829 Reduced 13.58%	947,000 $57.8 Million
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $9.35 Million - $11.8 Million	-205,945 Reduced 15.82%	1,095,829 $51.2 Million
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $34.5 Million - $44.6 Million	811,174 Added 165.34%	1,301,774 $66.1 Million
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $24.4 Million - $44.8 Million	-755,101 Reduced 60.62%	490,600 $21.9 Million
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $36.8 Million - $57.2 Million	-1,142,906 Reduced 47.85%	1,245,701 $59.8 Million
Q3 2019 Nov 15, 2019	SELL	$33.82 - $48.17 $8.92 Million - $12.7 Million	-263,840 Reduced 9.95%	2,388,607 $80.8 Million
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $8.96 Million - $11.4 Million	-252,946 Reduced 8.71%	2,652,447 $119 Million
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $40.5 Million - $56.9 Million	1,440,576 Added 98.35%	2,905,393 $109 Million
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $41 Million - $64 Million	1,375,917 Added 1547.71%	1,464,817 $50.3 Million
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $3.01 Million - $4.25 Million	88,900 New	88,900 $4.18 Million
Q4 2017 Feb 14, 2018	SELL	$15.14 - $20.89 $6.06 Million - $8.36 Million	-400,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $6.72 Million - $8.64 Million	400,000	400,000 $8 Million

Others Institutions Holding PTCT

# of Institutions

215

Shares Held

79.2M

Call Options Held

122K

Put Options Held

212K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.54B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account